These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2684709)

  • 1. Type II diabetes, glucose "non-sense," and islet desensitization.
    Robertson RP
    Diabetes; 1989 Dec; 38(12):1501-5. PubMed ID: 2684709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet dysfunction in non-insulin-dependent diabetes mellitus.
    Kahn SE; Porte D
    Am J Med; 1988 Nov; 85(5A):4-8. PubMed ID: 3057894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
    Porte D
    Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
    Nesher R; Warwar N; Khan A; Efendic S; Cerasi E; Kaiser N
    Diabetes; 2001 Feb; 50(2):308-14. PubMed ID: 11272141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective insulin secretion in NIDDM: integral part of a multiplier hypothesis.
    Robertson RP
    J Cell Biochem; 1992 Mar; 48(3):227-33. PubMed ID: 1400609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice.
    Jansson L; Eizirik DL; Pipeleers DG; Borg LA; Hellerström C; Andersson A
    J Clin Invest; 1995 Aug; 96(2):721-6. PubMed ID: 7635965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus.
    Ward WK; Beard JC; Porte D
    Diabetes Metab Rev; 1986; 2(3-4):297-313. PubMed ID: 3527617
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
    Porte D; Kahn SE
    Am J Med; 1991 Jun; 90(6A):8S-14S. PubMed ID: 1872310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between glucose utilization by tissues and residual insulin secretion and their role in the genesis of hyperglycemia in type I diabetes mellitus].
    Starostina EG; Lobanova AM; Magomedova AK
    Probl Endokrinol (Mosk); 1992; 38(3):15-8. PubMed ID: 1513782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Pfeifer MA; Porte D
    Diabetes Care; 1984; 7(5):491-502. PubMed ID: 6094129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.
    DeFronzo RA
    Diabetes; 1988 Jun; 37(6):667-87. PubMed ID: 3289989
    [No Abstract]   [Full Text] [Related]  

  • 13. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
    Polonsky KS
    Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic islet defects in NIDDM.
    Halter JB
    Prog Clin Biol Res; 1988; 265():1-12. PubMed ID: 3043439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2.
    Guillam MT; Hümmler E; Schaerer E; Yeh JI; Birnbaum MJ; Beermann F; Schmidt A; Dériaz N; Thorens B
    Nat Genet; 1997 Nov; 17(3):327-30. PubMed ID: 9354799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose.
    Ritzel RA; Hansen JB; Veldhuis JD; Butler PC
    J Clin Endocrinol Metab; 2004 Feb; 89(2):795-805. PubMed ID: 14764798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus.
    Alarcón C; Leahy JL; Schuppin GT; Rhodes CJ
    J Clin Invest; 1995 Mar; 95(3):1032-9. PubMed ID: 7883951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucotoxicity and insulin secretion. An excessively reductionistic formulation].
    Portha B; Ktorza A
    Journ Annu Diabetol Hotel Dieu; 1996; ():121-31. PubMed ID: 8965414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.